Zuardi et al., 2006, Cannabidiol, a Cannabis sativa constituent, as an
antipsychotic drug, BCraanznilaiabnid Jiooul ransa al no fa
Mntiepdsiyccahl oatnicd dBriuoglogical Research (2006) 39: 421-429
http://www.scielo.br/pdf/bjmbr/v39n4/6164.pdf
A snip from the abstract says it all but the paper is worth a read.
"
In addition, open case reports of schizophrenic patients
treated with CBD and a preliminary report of a controlled clinical trial
comparing CBD with an atypical antipsychotic drug have confirmed
that this cannabinoid can be a safe and well-tolerated alternative
treatment for schizophrenia.
"
Already a synthetic form of delta-9-THC has been licensed in America for
eating problems in AIDS and cancer patients, Marinol. Sativex was the
first medicine to come from cannabis.
The next line is also noteworthy.
"
Future studies of CBD in other psychotic conditions such as bipolar
disorder and comparative studies of its antipsychotic effects with those
produced by clozapine in schizophrenic patients are clearly indicated.
"
But instead most of the clozapine research focuses on trying to get it
used on more people and on children rather than investigating whether
this compound found in cannabis - usually at high levels in herbal
cannabis and hashish - could be used as a treatment. Instead the only
paper recently published in the NHS Evidence email looking for
alternatives to clozapine was written by someone from an eating
disorders clinic.
Guess psychiatrists really don't give a shit about another dead
clozapine victim. They're interested in injecting people with
delta-9-THC and looking to vilify cannabis more yet when it offers hope
for a better treatment that won't kill schizophrenics they daly around
doing whatever they do.
Let wisdom guide? LOL. Let the Royal College of Psychiatry suck on my
chocolate salty balls.
No comments:
Post a Comment